Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | — | — |
coughing; some vision issues; Initial information received on 15-Oct-2025 regarding an unsolicited valid non-serious case received from Patient. This case involves an unknown age/gender patient who experienced coughing and some vision issues after receiving vaccine INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in 2024, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE, Suspension for injection (dose, strength, lot, expiry, route and administration site: unknown) for prophylactic vaccination (immunization). On an unknown date in 2024, the patient developed a non-serious coughing (cough) and some vision issues (visual impairment) (unknown latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (coughing, some vision issues). At time of reporting, the outcome was Unknown for the events (coughing, some vision issues).